Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | Chief Commercial Officer | $437 K | -$9.1 K | -2.04% | Apr 16, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|